ARDELYX, INC. — Director's Dealing 2017

Jan 24, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARDELYX, INC. (ARDX)
CIK: 0001437402
Period of Report: 2017-01-05

Reporting Person: Korner Paul (EVP, Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-01-05	Common Stock	S	6130	$12.95	Disposed	54623	Direct

Footnotes

F1: The shares were automatically sold pursuant to the Issuer's 2014 Equity Incentive Award Plan to cover tax liability upon the vesting of outstanding Restricted Stock Units ("RSUs").

F2: Includes 45,565 RSUs. The reporting person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.